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A B S T R A C T
Equine coital exanthema (ECE) is an infectious, venereally transmitted muco-cutaneous disease aﬀecting mares
and stallions, caused by equid alphaherpesvirus 3 (EHV3). Diagnostic tools for rapid identiﬁcation of EHV3 are
of primary importance to diminish the risk of EHV3 dissemination at the time of breeding. In the last years, it has
been shown that the performance of the insulated-isothermal polymerase chain reaction (iiPCR) is comparable to
virus isolation, nested PCR and real-time PCR (qPCR) in detecting pathogens of various animal species.
Analytical sensitivity and speciﬁcity of the iiPCR were compared with a qPCR, using a plasmid containing the
target region of the EHV3 glycoprotein G gene and an Argentinian EHV3 isolate (E/9283/07 C3A). In order to
evaluate the diagnostic performance of the iiPCR, nucleic acids of 85 perineal and genital swabs (PGS) of mares
and stallions were extracted by tacoTM mini and tested by both techniques. EHV3 was detected in 46 and 45 of
the 85 PGS by the iiPCR and qPCR, respectively. There was almost perfect agreement between the two diagnostic
methods (98.82%; 95% CI: 95.03–100%; κ=0.98). The iiPCR had a limit of detection of 95.00% at 6 genome
equivalents per reaction and a detection endpoint for viral DNA comparable to that of the qPCR, and did not
react with six non-targeted equine pathogens. The iiPCR represents a sensitive and speciﬁc method for the rapid
on-site diagnosis of EHV3 infection. Its routinely implementation in breeding facilities, and artiﬁcial in-
semination and embryo transfer centers, will contribute to prevent the dissemination of this venereal, highly
contagious disease in horses.
1. Introduction
Equid alphaherpesvirus 3 (EHV3) is a member of the order
Herpesvirales, family Herpesviridae and belongs to the genus
Varicellovirus (Davison, 2010). EHV3, which is the causative agent of
equine coital exanthema (ECE), has a worldwide distribution and is
antigenically, genetically, and pathogenically distinct from the other
equid herpesviruses. ECE is a venereal and highly contagious disease,
characterized by the formation of papules, vesicles, pustules and ulcers
on the external genitalia of mares and stallions. Stallions with extensive
ECE lesions may walk stiﬄy, display general discomfort and loss of the
libido, and refuse to mate mares (Allen and Umphenour, 2004;
Barrandeguy and Thiry, 2012). The virus is primarily transmitted by
sexual intercourse or direct contact with contaminated objects such as
inspection gloves, ultrasound scanner or other used for the hygiene of
the genital area (Allen and Umphenour, 2004; Barrandeguy and Thiry,
2012). As for other herpesvirus infections, latency and reactivation are
critical events in their epidemiology. With respect to EHV3, in latently
infected horses, episodes of reactivation and re-excretion, either with or
without the manifestation of typical lesions, and together with variable
levels of serum antibodies, have been demonstrated, being these horses
the source of virus for other animals (Allen and Umphenour, 2004;
Barrandeguy, 2010; Barrandeguy et al. 2008; Barrandeguy et al.
(2010)).
The negative impact of ECE on the equine industry, mainly in the
thoroughbred breed, is the forced and temporary disruption of the
mating activities of aﬀected stallions and mares, which is translated
into signiﬁcant end-of-season decreases in the number of entries into
the mare book of the aﬀected stallions, and also delaying foaling dates
or reducing pregnancy rates in mares that miss breeding opportunities
due to the disease (Allen and Umphenour, 2004; Barrandeguy and
Thiry, 2012). Similarly, in artiﬁcial insemination and embryo transfer
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centers, aﬀected mares are reluctant to be inspected, inseminated or
transferred with the consequent loss of opportunity to be pregnant.
Moreover, additional time and necessary precautions which are re-
quired to manage the mares also have a substantial negative impact
(Barrandeguy and Thiry, 2012).
The diagnosis of ECE relies mainly on clinical inspection, and it can
be conﬁrmed, so far, by virus isolation or EHV3 DNA detection, by
conventional or real-time PCR (qPCR). However, both types of diag-
nosis (clinical inspection and laboratory tests) are not proper enough to
detect EHV3 before mating. On one hand, sub-clinical infections cannot
be detected by clinical inspection before mating; on the other hand,
EHV3 diagnosis can only be conducted in a specialized virology la-
boratory, and is not useful before mating. Diagnostic tools for on-site
identiﬁcation of EHV3 are of primary importance to prevent the risks of
EHV3 dissemination at the time of breeding or of embryo transfer
procedures, from mares which are shedding the virus sub-clinically. In
recent years, a PCR detection platform based on the ﬂuorescent probe
hydrolysis-based insulated isothermal PCR (iiPCR) technology has be-
come commercially available. With the ﬁeld-deployable PCR device
(POCKITTM Nucleic Acid Analyzer; POCKITTM; GeneReach USA,
Lexington, MA, USA) the entire reaction, known as iiPCR, can auto-
matically be developed obtaining the results within one hour (Tsai
et al., 2014, 2012). In the last years, it has been shown that the per-
formance of iiPCR assays is comparable to virus isolation in tissue
culture, nested PCR, and/or qPCR in detecting equine viruses (speciﬁ-
cally Equid herpesvirus 1 [EHV1], equine inﬂuenza virus [H3N8 sub-
type], equine arteritis virus [EAV]), other etiological agents of eco-
nomic and companion animals, and human pathogens (Ambagala et al.,
2015; Balasuriya et al., 2017, 2014; Carossino et al., 2016; Go et al.,
2017, 2016; Lung et al., 2016; Soltan et al., 2016; Wilkes et al., 2015b,
2017, 2015a; Zhang et al., 2016). Essentially, the POCKITTM system is
ready in a format for point-of-need applications. The reagents are lyo-
philized to facilitate long-term storage and easy shipping; a ﬁeld-de-
ployable, automated nucleic acid extraction system (tacoTM mini Nu-
cleic Acid Automatic Extraction System, tacoTM mini; GeneReach USA)
is also provided for easy and quick on-site nucleic acids extraction.
The aim of this study was to develop and validate the iiPCR test for
EHV3 detection, assessing its analytical sensitivity and speciﬁcity, as
well as its performance with clinical samples, comparing it with a real-
time PCR.
2. Materials and methods
2.1. Clinical samples
The well characterized EHV3 strain (E/9283/07 C3A)
(Barrandeguy, 2010) was used as reference (positive control). The virus
was ten-folded diluted (10−1 up to 10−7) in D-MEM, being the initial
titer 105.36 plaque forming units/ml.
A panel of 85 perineal-genital swabs (PGS) of mares and stallions
with and without clinical ECE lesions (n: 40) and of experimentally
EHV3 infected mares (n: 45) (Barrandeguy et al., 2012) were tested in
this study. All these clinical samples had been tested as EHV3 positive
and negative by conventional and qPCR (Barrandeguy et al., 2008;
Dynon et al., 2001).
In order to determine the speciﬁcity of the iiPCR assay, other equine
pathogens (one reference strain of EHV1 [Cornell University, Ithaca,
Nueva York, USA]; one Equid herpesvirus 4 [EHV4, Cornell University,
Ithaca, Nueva York, USA]; one Equid herpesvirus 2 [EHV2, Cornell
University, Ithaca, Nueva York, USA]; six EHV1 and three EHV4 ﬁeld
isolates [Argentina]; the modiﬁed live virus [MLV] vaccine strain of
EAV ARVAC®; one EAV contaminated semen; a ﬁeld isolate of
Salmonella enterica serovar Abortusequi, and two isolates of
Streptococcus equi Beta hemolytic Group C Lanceﬁeld) were included in
the study.
2.2. Nucleic acid extraction
Nucleic acids were extracted from clinical perineal-genital swab
samples using the tacoTM mini method. Brieﬂy, 200 μl of the samples
were added into the ﬁrst well of a tacoTM Preloaded DNA/RNA
Extraction plate (GeneReach USA) and subjected to the extraction steps
as described in the user manual. The nucleic acids were eluted in 200 μl
Eluting Buﬀer, transferred to fresh tubes, and stored at−70 °C for later
use. Nucleic acids from virus and bacteria isolates were extracted using
the High Pure PCR Template Preparation Kit® (Cat No. 11 796 828 001;
ROCHE, Indianapolis, Indiana, USA) following the instructions of the
manufacturer.
2.3. EHV3 qPCR and iiPCR
The TaqMan® ﬂuorogenic probe-based qPCR assay targeting EHV3
glycoprotein G (gG) gene was performed, using TaqMan Universal
Master Mix (Applied Biosystems®, Foster City, California, USA). Primers
and probe are described in Table 1, and the program (one step at 50 °C
for 2min, one step at 95 °C for 10min and 40 steps at 95 °C 15 s and at
60 °C 1min) was run in the Applied Biosystems® ABI-7500
(Barrandeguy et al., 2008).
The EHV3 iiPCR was designed based on a previously described
probe hydrolysis-based iiPCR method (Chang et al., 2012). Primer pair
and probe (Table 1) were designed to target a region of the gG gene of
EHV3 according to the recommended principles for iiPCR (http://www.
iipcr.com/eweb/uploadﬁle/20130522114104277.pdf). The POCKITTM
device has one default program for both PCR and reverse transcription
(RT)-PCR, including a step at 50 °C for 10min (for RT) and a step at
95 °C for 30min (for PCR). The reaction is completed in 50min. The
POCKITTM device collected optical signals through an image sensor.
Signal-to-noise (S/N) ratios were calculated by dividing light signals
collected after iiPCR by those from before iiPCR (Tsai et al., 2012).
According to the default S/N thresholds, results were converted auto-
matically to ‘positive’ or ‘negative’ and shown on the display screen
(Chang et al., 2012).
2.4. Statistical analysis
Limit of detection 95% (LoD 95%) of the reaction was determined
by probit analysis at 95% conﬁdence interval by SPSS version 14 (SPSS,
Chicago, IL, USA). The 2×2 contingency tables were analyzed by
Table 1
Sequences of primers and probes used in the qPCR and iiPCR assays targeting the conserved gG gene of EHV3 genome.
Name Sequence (5´–3´) Positiona Target Function Reference
EHV-3 Fw GGGTATCGGCTTTCTCATCTTG 133342–133363 gG gene qPCR Barrandeguy et al. (2008)
EHV-3 Rv CCGCAGGACGCAAACG 133411–133396 gG gene qPCR
EHV-3 Probe 6-FAM-TGTGTCTCCTCATCGGCCTCATTGTCT-TAMRA 133368–133394 gG gene qPCR
EHV-3 ii-F GGGCCCGACTTGTATAGCG 132632–132650 gG gene iiPCR this paper
EHV-3 ii-R TCCCGTGGGTCATTTTGCA 132710–132692
EHV-3 ii-Probe ATCTCCCTGCGCGTAAGCC 132656–132674
a Nucleotide position is based on GenBank accession number KM051845.
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kappa statistic using SPSS version 14 (SPSS, Chicago, IL, USA) to de-
termine the inter‐rater agreement (Cortés-Reyes et al., 2010; Eliasson
et al., 2017).
3. Results
3.1. Analytical sensitivity of EHV3 iiPCR
A serial dilution of the plasmid containing the target sequences was
used to determine the sensitivity of the EHV3 iiPCR assay. The per-
centage of positive results was 100% (10/10), 100% (20/20), 100%
(20/20), 80% (16/20) and 0% (0/24) for 100, 50, 20, 5 and 0 copies of
plasmid DNA, respectively. Calculation by probit regression analysis
determined that the LoD 95% of the reaction was 6 copies genome
equivalents per reaction. In addition, the analytical sensitivity of the
iiPCR for EHV3 detection was compared to that of the published EHV3
qPCR (Barrandeguy et al., 2008). Both PCR methods tested positive
with all the replicates of the dilution 10−4 (3/3) (Table 2), indicating
that the two had comparable detection limits for EHV3 genomic DNA.
3.2. Analytical speciﬁcity of EHV3 iiPCR
Analytical speciﬁcity of the EHV3 iiPCR assay on the POCKITTM
device was veriﬁed with a panel of six equine pathogens (seven EHV1,
one EHV2, four EHV4, two EAV, one S. enterica serovar. Abortusequi
and two S. equi). None of the six pathogens were detected indicating
that the iiPCR has high analytical speciﬁcity.
3.3. Diagnostic sensitivity and speciﬁcity of EHV3 iiPCR
The diagnostic performance of the EHV3 iiPCR/POCKITTM assay to
detect EHV3 in equine clinical samples was compared to that of the
reference qPCR. After testing 85 PGS from mares and stallions with or
without ECE lesions, EHV3 was detected in 46 and 45 of the PGS
samples by the iiPCR and qPCR, respectively (Table 1). The two
methods had 98.82% agreement (95% conﬁdence interval [CI]:
95.03%–100%, κ=0.98). Both speciﬁcity and sensitivity were de-
termined as 98.34% (95% CI: 91.20%–100%) and 100% (95% CI:
93.30%–100%), respectively (Table 3).
4. Discussion
In the present study, we developed and validated an iiPCR for the
rapid detection of EHV3 nucleic acid in PGS of mares and stallions.
Similar to the qPCR, this assay is based on TaqMan® probe hydrolysis to
generate a ﬂuorescent signal and requires no post- reaction handling of
amplicons, thus reducing the risks of carry-over contamination of
samples.
In addition to the advantages of the iiPCR reaction, the nucleic acid
extraction system is very simple. Most of the available nucleic acid
extraction methods are labour-intensive and require trained technicians
to be performed. Simpliﬁed column-based extraction systems are
available to isolate nucleic acids from clinical samples in the ﬁeld
(Ambagala et al., 2015), but still require a considerable manual hand-
ling with the potential risks of target contaminations and/or nucleic
acid degradation. The fully automated ﬁeld-deployable tacoTM mini
system can be used to facilitate easy and consistent nucleic acid ex-
traction in the ﬁeld, greatly reducing hands-on time from samples to
results.
The analytical sensitivity of the iiPCR (98.34%) was similar to that
of the previously described qPCR (Barrandeguy et al., 2008); however,
iiPCR has more than one additional advantage: a very simple carry-out
protocol; performance in a portable device (POCKITTM) using lyophi-
lized reagents; and results obtained, as positive or negative, after au-
tomatic data processing in only 50min.
Furthermore, the iiPCR assay was highly speciﬁc for EHV3, as it did
not cross-react with other common equine viral (EHV1, 4, 2 and EAV)
and bacterial (S. enterica serovar Abortusequi and S. equi Beta hemolytic
Group C Lanceﬁeld) pathogens.
The diagnostic sensitivity and speciﬁcity of the newly developed
EHV3 iiPCR assay on PGS samples of mares and stallions were com-
parable to those of the previously described EHV3 qPCR assay, with an
agreement of 98.82%. The only one discrepant result corresponded to a
PGS sample from a mare experimentally infected in its last day of EHV3
shedding period (iiPCR+/nested PCR+/conventional PCR−/real
time−/virus isolation -; data not shown).
Overall, the combination of a quick nucleic acid extraction (25min)
with tacoTM mini and the DNA ampliﬁcation with iiPCR/POCKITTM
(POCKITTM Combo, GeneReach USA) which are available in a durable
suitcase to serve as a mobile laboratory, allow the detection of EHV3 in
PGS of mares or stallions, and can generate qualitative test results
within 90min. The high sensitivity and speciﬁcity of the EHV3 iiPCR on
the POCKITTM Combo system demonstrated by this study, support its
use as a rapid screening test before mating activities in breeding farms.
Thus, the use of this methodology in breeding farms would facilitate the
rapid identiﬁcation of EHV3 in animals which are sub-clinically shed-
ding the virus at the time of mating. Similarly, its use in artiﬁcial in-
semination and embryo transfer centers would allow the rapid diag-
nosis of outbreaks of ECE. In both cases, the use of the EHV3 iiPCR on
the mobile PCR/POCKITTM system can be considered an important tool
in the implementation of ECE control and prevention strategies, and
therefore diminish the risks of virus transmission in breeding facilities,
and in artiﬁcial insemination and embryo transfer centers.
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Table 2
Comparison of the analytical sensitivity between the EHV3 iiPCR and qPCR
assays using a reference strain of EHV3 (E/9283/07 C3A).
Sample Dilutionsa POCKIT PCR Real-time PCRa (result/Ct value)
10−2 + + nd +/28.5 +/28.4 +/28.5
10−3 + + + +/32.16 +/31.96 +/31.82
10−4 + + + +/36.39 +/36.18 +/36.47
10−5 + + – +/39.42 +/38.21 −/ND
10−6 – – – +/39.32 +/39.28 −/ND
a Nucleic acids extracted from serial dilutions (10−1 to 10-7) of EHV3 (E/
9283/07 C3A) made in DMEM; +, positive;−, negative; nd, not done; ND, not
detected.
Table 3
Contingency table for analysis of the agreement between the qPCR and the




EHV3 POCKIT PCR Positive 45 1 46
Negative 0 39 39
Total 45 40 85
Agreement: 98.82% (95%CI: 95.03–100%).
Kappa Value (agreement beyond chance)= 0.98.
Speciﬁcity: 98.34% (95%CI: 91.20%–100%); Sensitivity: 100% (95%CI:
93.30% - 100%).
Bold values signiﬁes the total value of each group.
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